RSS   Newsletter   Contact   Advertise with us
Post Online Media

Flexion Therapeutics appoints Mark Stejbach to board

Flexion TherapeuticsFlexion Therapeutics, Inc., a specialty pharmaceutical company, appoints Mark Stejbach to its board of directors.
Article continues below

READ MORE Flexion adds Scott Canute to board of directors

Mr. Stejbach has more than 25 years of leadership experience in biotech and commercial marketing, sales, managed care, and finance.

Prior to that he served as Senior Vice President and Chief Commercial Officer at Alkermes plc.

Previously, he served at Tengion, Inc. from 2008 to 2012, most recently as Chief Commercial Officer. He previously held senior positions at Merck & Co. and Biogen Idec.

Mr. Stejbach received his MBA from the University of Pennsylvania and a Bachelor of Science in mathematics from Virginia Tech.

 LATEST MOVES FROM Massachusetts 


We use cookies to ensure that we give you the best experience on our website. Please allow cookies for fully-functioning website.

Allow Cookies Privacy Policy